Cellectar Biosciences, Inc. — Director's Dealing 2014

Dec 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-11-24

Reporting Person: Szakacs Cameron (VP of Clinical Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-24	Employee Stock Option (right to buy)	$2.74	A	50000	Acquired	2024-11-24	Common Stock (50000)	Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant.